Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer

JCO Precis Oncol. 2019:3:PO.19.00011. doi: 10.1200/PO.19.00011. Epub 2019 May 10.
No abstract available